100 related articles for article (PubMed ID: 21465478)
1. The tumor suppressor role of CTCF.
Fiorentino FP; Giordano A
J Cell Physiol; 2012 Feb; 227(2):479-92. PubMed ID: 21465478
[TBL] [Abstract][Full Text] [Related]
2. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
Soto-Reyes E; Recillas-Targa F
Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
[TBL] [Abstract][Full Text] [Related]
5. Insulation of tumor suppressor genes by the nuclear factor CTCF.
Recillas-Targa F; de la Rosa-Velázquez IA; Soto-Reyes E
Biochem Cell Biol; 2011 Oct; 89(5):479-88. PubMed ID: 21846316
[TBL] [Abstract][Full Text] [Related]
6. CTCF and BORIS in genome regulation and cancer.
Marshall AD; Bailey CG; Rasko JE
Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
[TBL] [Abstract][Full Text] [Related]
7. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
9. Dynamic association of the mammalian insulator protein CTCF with centrosomes and the midbody.
Zhang R; Burke LJ; Rasko JE; Lobanenkov V; Renkawitz R
Exp Cell Res; 2004 Mar; 294(1):86-93. PubMed ID: 14980504
[TBL] [Abstract][Full Text] [Related]
10. CTCF function is modulated by neighboring DNA binding factors.
Weth O; Renkawitz R
Biochem Cell Biol; 2011 Oct; 89(5):459-68. PubMed ID: 21895576
[TBL] [Abstract][Full Text] [Related]
11. CCCTC-binding factor meets poly(ADP-ribose) polymerase-1.
Caiafa P; Zlatanova J
J Cell Physiol; 2009 May; 219(2):265-70. PubMed ID: 19170077
[TBL] [Abstract][Full Text] [Related]
12. CTCF binds the proximal exonic region of hTERT and inhibits its transcription.
Renaud S; Loukinov D; Bosman FT; Lobanenkov V; Benhattar J
Nucleic Acids Res; 2005; 33(21):6850-60. PubMed ID: 16326864
[TBL] [Abstract][Full Text] [Related]
13. CTCF maintains differential methylation at the Igf2/H19 locus.
Schoenherr CJ; Levorse JM; Tilghman SM
Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
Esteves LI; Javaroni AC; Nishimoto IN; Magrin J; Squire JA; Kowalski LP; Rainho CA; Rogatto SR
Mol Carcinog; 2005 Oct; 44(2):102-10. PubMed ID: 16015666
[TBL] [Abstract][Full Text] [Related]
15. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation.
Pugacheva EM; Tiwari VK; Abdullaev Z; Vostrov AA; Flanagan PT; Quitschke WW; Loukinov DI; Ohlsson R; Lobanenkov VV
Hum Mol Genet; 2005 Apr; 14(7):953-65. PubMed ID: 15731119
[TBL] [Abstract][Full Text] [Related]
16. Aberrant CBFA2T3B gene promoter methylation in breast tumors.
Bais AJ; Gardner AE; McKenzie OL; Callen DF; Sutherland GR; Kremmidiotis G
Mol Cancer; 2004 Aug; 3():22. PubMed ID: 15301688
[TBL] [Abstract][Full Text] [Related]
17. Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF.
Rasko JE; Klenova EM; Leon J; Filippova GN; Loukinov DI; Vatolin S; Robinson AF; Hu YJ; Ulmer J; Ward MD; Pugacheva EM; Neiman PE; Morse HC; Collins SJ; Lobanenkov VV
Cancer Res; 2001 Aug; 61(16):6002-7. PubMed ID: 11507042
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic control of expression of the human L- and M- pigment genes.
Deeb SS; Bisset D; Fu L
Ophthalmic Physiol Opt; 2010 Sep; 30(5):446-53. PubMed ID: 20883327
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
Butcher DT; Rodenhiser DI
Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
[TBL] [Abstract][Full Text] [Related]
20. CTCF, cohesin, and histone variants: connecting the genome.
Millau JF; Gaudreau L
Biochem Cell Biol; 2011 Oct; 89(5):505-13. PubMed ID: 21970734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
